Mayo Clinic
Clinical trials sponsored by Mayo Clinic, explained in plain language.
-
Phone calls and pills: a new strategy to keep lung surgery patients out of the hospital
Disease control TerminatedThis study tested whether giving patients antibiotics and making regular phone check-ins after they go home with a chest tube could prevent serious infections and reduce return trips to the hospital. It involved 25 adults who had lung surgery and were discharged with a tube still…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 04, 2026 03:51 UTC
-
Oral drug combo tested for rare blood cancer
Disease control TerminatedThis study tested a combination of two oral drugs, ibrutinib and ixazomib, for people with Waldenström macroglobulinemia, a rare type of blood cancer. The goal was to see if taking these two drugs together was safe and effective at controlling the cancer. The trial was designed f…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 04, 2026 03:49 UTC
-
Drug trial halted early in bid to protect transplanted livers
Disease control TerminatedThis study tested whether a daily pill called fenofibrate could prevent a serious complication called ischemic cholangiopathy, which damages the bile ducts, in people who received a liver from a donor after their heart stopped. It was a small pilot study with 6 participants who h…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New pill tested to fight tough bile duct cancer
Disease control TerminatedThis early-stage study aimed to find a safe dose and test the initial effects of a new oral drug called NXP800 for patients with advanced bile duct cancer (cholangiocarcinoma) that had spread or stopped responding to standard treatments. The drug works by blocking a specific path…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists fight cancer with measles virus in groundbreaking trial
Disease control TerminatedThis study tested whether a specially engineered measles virus could be a better treatment than standard chemotherapy for women with advanced ovarian, fallopian, or peritoneal cancer that had stopped responding to platinum-based drugs. Participants were randomly assigned to recei…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Direct-to-Lymph node cancer treatment tested in early trial
Disease control TerminatedThis early-phase study tested the safety and best dose of an immunotherapy drug called STI-3031. The drug was delivered directly into the lymph vessels or nodes of a single limb using a special device, aiming to treat melanoma that had spread locally. The goal was to see if this …
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New combo therapy tested for Tough-to-Treat lung cancer
Disease control TerminatedThis study tested whether adding an immunotherapy drug called bintrafusp alfa to standard chemotherapy (docetaxel) could better control advanced non-small cell lung cancer in patients whose cancer had worsened despite previous treatment with immunotherapy and chemo. The trial aim…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Doctors test engineered virus to attack deadly skin cancer
Disease control TerminatedThis early-phase study tested a genetically modified virus designed to kill melanoma cancer cells. The virus was injected directly into tumors and given intravenously to patients with advanced melanoma that had stopped responding to standard treatments. The main goals were to fin…
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Genetic map guides fight against multiple lung tumors
Disease control TerminatedThis study tested a personalized treatment plan for patients with multiple early-stage lung tumors. Doctors used genetic sequencing of the tumors to guide a combination of targeted drug therapy and surgery or radiation. The goal was to see if this aggressive, tailored approach co…
Phase: NA • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Halted trial tests new shot for rare bone marrow cancer
Disease control TerminatedThis study tested whether a drug called P1101 could help control myelofibrosis, a rare cancer that scars the bone marrow. It involved 11 patients with early-stage disease who received injections every two weeks. The main goal was to see if the treatment could shrink enlarged sple…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Targeted radiation blast tested to slow advanced pancreatic cancer
Disease control TerminatedThis study tested if adding a precise, high-dose form of radiation therapy to standard chemotherapy could better control pancreatic cancer that had spread to only a few other places in the body. It aimed to see if this combination could slow the cancer's progression and help pati…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
New drug tested to fight back against stubborn breast cancer
Disease control TerminatedThis study tested if a drug called abemaciclib could help control a hard-to-treat type of breast cancer that did not fully respond to standard chemotherapy. It involved 26 women whose cancer could still be surgically removed. The goal was to see if taking the drug for a short per…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
Precision proton beams aim to zap liver tumors
Disease control TerminatedThis study tested a focused form of proton radiation therapy for adults with liver cancer. The main goal was to see if this treatment was safe for the liver and to measure how well it controlled the tumors. The trial was small and ended early, so its results are limited.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Two-Drug attack tested for stubborn blood cancer
Disease control TerminatedThis study tested whether combining two drugs, daratumumab and ibrutinib, works better than ibrutinib alone for patients whose chronic lymphocytic leukemia (CLL) has come back or stopped responding to previous treatments. Daratumumab helps the immune system target cancer cells, w…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Radiation 'Grid' tried to reboot failed cancer drug
Disease control TerminatedThis small, early-stage study tested if a special, targeted radiation technique called 'grid therapy' could help the immunotherapy drug durvalumab work again for patients with non-small cell lung cancer. The patients had already tried durvalumab, but their cancer started growing …
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC
-
New scan aims to solve brain cancer mystery
Diagnosis TerminatedThis study tested a special brain scan to see if it could better tell whether a brain tumor had returned or if brain changes were due to injury from previous radiation therapy. It involved 19 patients with cancer that had spread to the brain. The goal was to improve diagnosis to …
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Apr 02, 2026 14:58 UTC
-
Microscope-in-a-Needle aims for faster lung cancer answers
Diagnosis TerminatedThis study tested whether adding a special microscopic camera (called nCLE) to a standard lung biopsy procedure could help doctors diagnose lung cancer more quickly and accurately. Patients with suspicious lung nodules were randomly assigned to get either the standard biopsy or t…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Apr 02, 2026 14:57 UTC
-
Could a simple urine test spot prostate cancer?
Diagnosis TerminatedThis study aimed to see if a new test could detect prostate cancer by looking for specific DNA markers in a person's urine. Researchers enrolled 24 men, some with confirmed prostate cancer and some scheduled for a biopsy, to collect urine samples. The goal was to check how accura…
Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 30, 2026 14:30 UTC
-
New device aims to spot brain danger without surgery
Diagnosis TerminatedThis study tested a device called Brain4Care that measures pressure inside the skull without surgery. It aimed to see if the device could safely and effectively detect dangerous pressure changes early in adults with brain lesions who were being monitored in intensive care. The go…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Smartwatch aims to replace finger pricks for blood sugar checks
Diagnosis TerminatedThis study tested whether a special smartwatch could accurately measure blood sugar and blood pressure without needles or traditional cuffs. It involved 87 hospitalized patients with diabetes who were already having their vital signs monitored. The goal was to compare the watch's…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 23, 2026 15:14 UTC
-
Electronic 'Nose' sniffs out who skipped breakfast before surgery
Diagnosis TerminatedThis study tested a device that analyzes a person's breath to see if they have properly fasted before a scheduled medical procedure. Researchers wanted to see if this quick, non-invasive check could help prevent procedure cancellations and improve patient safety. The study involv…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Mar 13, 2026 15:06 UTC
-
New surgery aims to stop debilitating arm swelling in cancer patients
Prevention TerminatedThis study tested whether a special surgical technique performed during lymph node removal could prevent lymphedema—a painful, chronic swelling of the arm. It involved 264 patients with breast cancer or melanoma who were having lymph nodes removed from their armpit. Half received…
Phase: NA • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Apr 03, 2026 14:41 UTC
-
New gel offers hope for breast cancer prevention with fewer side effects
Prevention TerminatedThis study aimed to find a better way to prevent breast cancer in women at high risk. It compared a standard oral pill (tamoxifen) to a new topical gel applied to the breast, hoping the gel would work just as well but cause fewer body-wide side effects. Researchers planned to che…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Apr 02, 2026 14:57 UTC
-
Pain block study for pancreas surgery ends early
Symptom relief TerminatedThis study aimed to compare two approaches for managing pain after major pancreas surgery (pancreaticoduodenectomy). Researchers wanted to see if a specific nerve block procedure provided better pain relief than standard care without the block. The trial was terminated early afte…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Apr 04, 2026 03:51 UTC
-
Doctors seek goldilocks dose: enough pain relief, fewer side effects for young spine patients
Symptom relief TerminatedThis study aimed to find the best dose of a strong pain medicine given directly into the spinal fluid for teenagers having major back surgery for scoliosis. Researchers tested different doses in a small group of patients to see which one provided the most pain relief while causin…
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Apr 03, 2026 14:42 UTC
-
Antibiotic tested for stomach bloating in diabetes patients
Symptom relief TerminatedThis study tested whether the antibiotic rifaximin could reduce bloating symptoms in people with diabetic gastroparesis, a condition where the stomach empties too slowly. Researchers enrolled adults aged 18-75 who had been diagnosed with diabetic gastroparesis and experienced blo…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC
-
Buzzing device tested for stubborn sinus pain
Symptom relief TerminatedThis study tested whether a handheld device called SinuSonic could reduce facial pain and pressure from sinus headaches. The device combines gentle vibration with breathing pressure. Researchers compared it to a fake device in a small group of adults with chronic facial pain.
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC
-
Zap your shot pain? device tested for migraine injection discomfort
Symptom relief TerminatedThis study tested if a wearable device called Nerivio could reduce the pain people feel when getting their regular Botox injections for chronic migraine. The device uses gentle electrical pulses on the arm to try to interfere with pain signals. The trial was stopped early and did…
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 30, 2026 14:35 UTC
-
Trial aims to tame harsh chemo gut side effects
Symptom relief TerminatedThis study tested whether the antibiotic rifaximin could reduce severe stomach pain, diarrhea, and other gut problems caused by a standard breast cancer drug combination. It involved 20 women with early-stage HER2-positive breast cancer who were experiencing these side effects. T…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
Doctors probe Heart's role in waking up from surgery
Knowledge-focused TerminatedThis study aimed to understand if the strength of a patient's heart pumping (cardiac output) affects how quickly they recover from muscle-relaxing drugs given during surgery. Researchers planned to measure this in adults having elective surgery. The study was terminated early aft…
Phase: NA • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:51 UTC
-
Doctors search for early warning signs of chemo heart damage
Knowledge-focused TerminatedThis study aims to find early markers that can predict which sarcoma patients are most at risk for heart damage from chemotherapy. Researchers will observe 400 adult patients receiving standard doxorubicin treatment at Mayo Clinic. They will use advanced heart imaging techniques …
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 04, 2026 03:50 UTC
-
Mayo clinic tests Smartwatch-Style tech to spot surgery trouble early
Knowledge-focused TerminatedThis study aimed to see if remote monitoring could help predict when patients might have problems recovering from major surgery. It involved 56 adults who tracked their daily exercise and symptoms using wearable devices and logs. The goal was to develop computer algorithms that c…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC
-
Mayo clinic builds cancer sample bank for future breakthroughs
Knowledge-focused TerminatedThis study created a registry to collect and store tissue and blood samples from patients undergoing surgery or biopsy for liver or bile duct tumors. The samples are used for future research to better understand these cancers and develop new treatments. The study enrolled 1,000 p…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists hunt for lung Cancer's genetic fingerprint
Knowledge-focused TerminatedThis study aimed to find genetic markers that could predict how quickly squamous cell lung cancer might worsen. Researchers collected small tissue and blood samples from patients who had or were having lung procedures. The goal was to analyze the DNA from these samples to identif…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Doctors probe link between hepatitis c and blood cell changes
Knowledge-focused TerminatedThis study aimed to understand how common a specific blood cell condition (monoclonal B-cell lymphocytosis) is in people with chronic hepatitis C. Researchers observed 29 participants to see if treating the hepatitis C virus affected this blood cell condition. The study was termi…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Mar 16, 2026 15:24 UTC